Patent ID: 11971411
Assignee: DANA-FARBER CANCER INSTITUTE, INC.
Field: Measurement (Instruments)
Classification: CPC G  C | IPC C  G

Claim 0:
1. A method of measuring the expression level of ZFP36 and PTEN in a subject having prostate cancer, the method consisting of:
a. measuring the binding of a first probe in a first sample from the subject, wherein the first probe specifically hybridizes to a nucleic acid having the sequence set forth in SEQ ID NO: 2, thereby measuring expression of ZFP36 in the subject, and
b. measuring the binding of a second probe in a second sample from the subject, wherein the second probe specifically hybridizes to a nucleic acid having the sequence set forth in SEQ ID NO: 15, 16, or 17, thereby measuring expression of PTEN in the subject.